newsfilter
← Latest News
GlobeNewswire·

Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results

Company Reports Strong Cash Position as it Prepares to Initiate a CD34+ Cell Therapy Study in Diabetic Kidney Disease Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Caladrius Bios